Letters to the Editor
Vol. 17 No. 1 (2025): Review Articles, Original Article, Scientific Letter, Case Reports Letter to the Editor
Direct oral anticoagulants (DOACs) in the onco-hematologic patients
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Received: December 29, 2024
Accepted: January 9, 2025
Accepted: January 9, 2025
886
Views
838
Downloads
53
HTML
Authors
Downloads
Download data is not yet available.
Citations
How to Cite
“Direct oral anticoagulants (DOACs) in the onco-hematologic patients” (2025) Mediterranean Journal of Hematology and Infectious Diseases, 17(1), p. e2025022. doi:10.4084/MJHID.2025.022.
Copyright (c) 2025 Mario Biglietto, Silvio Ligia, Alessandro Laganà, Giovanni Manfredi Assanto, Martina Gherardini, Erminia Baldacci, Cristina Santoro, Antonio Chistolini
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
